SCHEMBL4942917

SCHEMBL4942917

C[C@@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C(O)=C[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MBOAT4 Q96T53 2/20 0.47
SHBG P04278 2/20 0.46
GRIN2D O15399 2/20 0.45
GRIN1 Q05586 2/20 0.45
GRIN2A Q12879 2/20 0.45
GRIN2B Q13224 2/20 0.45
GRIN2C Q14957 2/20 0.45
GPBAR1 Q8TDU6 2/20 0.43
NR3C1 P04150 2/20 0.43
PGR P06401 2/20 0.43
CYP3A4 P08684 2/20 0.43
AR P10275 2/20 0.43
HSD17B10 Q99714 2/20 0.43
SERPINA6 P08185 1/20 0.43
NR3C2 P08235 1/20 0.43
CYP19A1 P11511 1/20 0.43
MGAM O43451 1/20 0.43
AKR1B10 O60218 2/20 0.40
AKR1B1 P15121 2/20 0.40
PRKCA P17252 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079593 0.84 MBOAT4 (0.44) MBOAT4SHBGGPBAR1NR3C1PGR
SCHEMBL21822078 0.79 CYP19A1 (0.53) MBOAT4SHBGGPBAR1CYP3A4SERPINA6
SCHEMBL28689586 0.79 MBOAT4 (0.74) MBOAT4SHBGGRIN1GRIN2BCYP19A1
SCHEMBL6477188 0.79 MBOAT4 (0.74) MBOAT4SHBGGRIN1GRIN2BCYP19A1
SCHEMBL28680586 0.79 MBOAT4 (0.74) MBOAT4SHBGGRIN1GRIN2BCYP19A1
SCHEMBL15518055 0.78 SRD5A1 (0.58) LMNA
SCHEMBL16057230 0.78 SRD5A1 (0.58) LMNA
SCHEMBL8898529 0.78 AR (0.45) SHBGGRIN2DGRIN1GRIN2AGRIN2B
SCHEMBL21807712 0.78 AR (0.45) SHBGGRIN2DGRIN1GRIN2AGRIN2B
SCHEMBL11332329 0.76 CYP19A1 (0.57) MBOAT4SHBGGPBAR1NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210346385-A1 TASTE-MASKED DOSAGE FORMS DEEP OCEAN CAPITAL MANAGEMENT LP 2021-11-11 US disclosed
US-20080075772-A1 PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS ACCU-BREAK TECHNOLOGIES, INC. 2008-03-27 US disclosed
WO-2004064722-A3 PROCESS FOR THE PRODUCTION OF OXANDROLONE ENDEAVOR PHARMACEUTICALS INC (US) 2004-11-18 WO disclosed
WO-2004064722-A2 PROCESS FOR THE PRODUCTION OF OXANDROLONE ENDEAVOR PHARMACEUTICALS, INCORPORATED (US) 2004-08-05 WO disclosed
WO-2004064722-A2 PROCESS FOR THE PRODUCTION OF OXANDROLONE ENDEAVOR PHARMACEUTICALS, INCORPORATED (US) 2004-08-05 WO disclosed